Carl Zeiss Meditec AG (BIT:1AFX)

Market Cap	3.55B
Revenue (ttm)	2.23B
Net Income (ttm)	141.21M
Shares Out	n/a
EPS (ttm)	1.61
PE Ratio	25.16
Forward PE	20.84
Dividend	0.60 (1.38%)
Ex-Dividend Date	Mar 27, 2025

Volume	3,375
Average Volume	377
Open	44.76
Previous Close	42.82
Day's Range	39.00 - 45.04
52-Week Range	39.00 - 71.10
Beta	n/a
RSI	34.28
Earnings Date	Dec 11, 2025

About Carl Zeiss Meditec AG

Carl Zeiss Meditec AG operates as a medical technology company in Germany, rest of Europe, North America, and Asia. It operates in two segments, Ophthalmology and Microsurgery. The Ophthalmology segment offers products and solutions for the diagnosis and treatment of chronic eye diseases, such as ametropia (refraction), cataracts, glaucoma, and renital disorders. This segment also provides devices for general ophthalmological examination and care, including slit lamps, refractometers, tonometers, optical coherence tomography devices, and fundus...

• Industry: Electromedical and Electrotherapeutic Apparatus
• Founded: 1846
• Employees: 5,784
• Stock Exchange: Borsa Italiana
• Ticker Symbol: 1AFX

Financial Performance

In 2025, Carl Zeiss Meditec AG's revenue was 2.23 billion, an increase of 7.82% compared to the previous year's 2.07 billion. Earnings were 141.21 million, a decrease of -20.99%.